Cargando…

Barriers to antiretroviral therapy adherence in rural Mozambique

BACKGROUND: HIV is treated as a chronic disease, but high lost-to-follow-up rates and poor adherence to medication result in higher mortality, morbidity, and viral mutation. Within 18 clinical sites in rural Zambézia Province, Mozambique, patient adherence to antiretroviral therapy has been sub-opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Groh, Kate, Audet, Carolyn M, Baptista, Alberto, Sidat, Mohsin, Vergara, Alfredo, Vermund, Sten H, Moon, Troy D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171727/
https://www.ncbi.nlm.nih.gov/pubmed/21846344
http://dx.doi.org/10.1186/1471-2458-11-650
_version_ 1782211790627667968
author Groh, Kate
Audet, Carolyn M
Baptista, Alberto
Sidat, Mohsin
Vergara, Alfredo
Vermund, Sten H
Moon, Troy D
author_facet Groh, Kate
Audet, Carolyn M
Baptista, Alberto
Sidat, Mohsin
Vergara, Alfredo
Vermund, Sten H
Moon, Troy D
author_sort Groh, Kate
collection PubMed
description BACKGROUND: HIV is treated as a chronic disease, but high lost-to-follow-up rates and poor adherence to medication result in higher mortality, morbidity, and viral mutation. Within 18 clinical sites in rural Zambézia Province, Mozambique, patient adherence to antiretroviral therapy has been sub-optimal. METHODS: To better understand barriers to adherence, we conducted 18 community and clinic focus groups in six rural districts. We interviewed 76 women and 88 men, of whom 124 were community participants (CP; 60 women, 64 men) and 40 were health care workers (HCW; 16 women, 24 men) who provide care for those living with HIV. RESULTS: While there was some consensus, both CP and HCW provided complementary insights. CP focus groups noted a lack of confidentiality and poor treatment by hospital staff (42% CP vs. 0% HCW), doubt as to the benefits of antiretroviral therapy (75% CP vs. 0% HCW), and sharing medications with family members (66% CP vs. 0%HCW). Men expressed a greater concern about poor treatment by HCW than women (83% men vs. 0% women). Health care workers blamed patient preference for traditional medicine (42% CP vs. 100% HCW) and the side effects of medication for poor adherence (8% CP vs. 83% CHW). CONCLUSIONS: Perspectives of CP and HCW likely reflect differing sociocultural and educational backgrounds. Health care workers must understand community perspectives on causes of suboptimal adherence as a first step toward effective intervention.
format Online
Article
Text
id pubmed-3171727
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31717272011-09-13 Barriers to antiretroviral therapy adherence in rural Mozambique Groh, Kate Audet, Carolyn M Baptista, Alberto Sidat, Mohsin Vergara, Alfredo Vermund, Sten H Moon, Troy D BMC Public Health Research Article BACKGROUND: HIV is treated as a chronic disease, but high lost-to-follow-up rates and poor adherence to medication result in higher mortality, morbidity, and viral mutation. Within 18 clinical sites in rural Zambézia Province, Mozambique, patient adherence to antiretroviral therapy has been sub-optimal. METHODS: To better understand barriers to adherence, we conducted 18 community and clinic focus groups in six rural districts. We interviewed 76 women and 88 men, of whom 124 were community participants (CP; 60 women, 64 men) and 40 were health care workers (HCW; 16 women, 24 men) who provide care for those living with HIV. RESULTS: While there was some consensus, both CP and HCW provided complementary insights. CP focus groups noted a lack of confidentiality and poor treatment by hospital staff (42% CP vs. 0% HCW), doubt as to the benefits of antiretroviral therapy (75% CP vs. 0% HCW), and sharing medications with family members (66% CP vs. 0%HCW). Men expressed a greater concern about poor treatment by HCW than women (83% men vs. 0% women). Health care workers blamed patient preference for traditional medicine (42% CP vs. 100% HCW) and the side effects of medication for poor adherence (8% CP vs. 83% CHW). CONCLUSIONS: Perspectives of CP and HCW likely reflect differing sociocultural and educational backgrounds. Health care workers must understand community perspectives on causes of suboptimal adherence as a first step toward effective intervention. BioMed Central 2011-08-16 /pmc/articles/PMC3171727/ /pubmed/21846344 http://dx.doi.org/10.1186/1471-2458-11-650 Text en Copyright ©2011 Groh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Groh, Kate
Audet, Carolyn M
Baptista, Alberto
Sidat, Mohsin
Vergara, Alfredo
Vermund, Sten H
Moon, Troy D
Barriers to antiretroviral therapy adherence in rural Mozambique
title Barriers to antiretroviral therapy adherence in rural Mozambique
title_full Barriers to antiretroviral therapy adherence in rural Mozambique
title_fullStr Barriers to antiretroviral therapy adherence in rural Mozambique
title_full_unstemmed Barriers to antiretroviral therapy adherence in rural Mozambique
title_short Barriers to antiretroviral therapy adherence in rural Mozambique
title_sort barriers to antiretroviral therapy adherence in rural mozambique
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171727/
https://www.ncbi.nlm.nih.gov/pubmed/21846344
http://dx.doi.org/10.1186/1471-2458-11-650
work_keys_str_mv AT grohkate barrierstoantiretroviraltherapyadherenceinruralmozambique
AT audetcarolynm barrierstoantiretroviraltherapyadherenceinruralmozambique
AT baptistaalberto barrierstoantiretroviraltherapyadherenceinruralmozambique
AT sidatmohsin barrierstoantiretroviraltherapyadherenceinruralmozambique
AT vergaraalfredo barrierstoantiretroviraltherapyadherenceinruralmozambique
AT vermundstenh barrierstoantiretroviraltherapyadherenceinruralmozambique
AT moontroyd barrierstoantiretroviraltherapyadherenceinruralmozambique